[Genetic polymorphism of drug oxidation: its importance in the use of antihypertensive drugs].
D000319:Adrenergic beta-Antagonists / Q000378:metabolism; D000818:Animals; D000959:Antihypertensive Agents / Q000378:metabolism*; D004983:Ethanolamines / Q000378:metabolism; D006801:Humans; D006900:Hydroxylation; D010084:Oxidation-Reduction; D011110:Polymorphism, Genetic; D051381:Rats; D012907:Smoking
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004983:Ethanolamines; C010831:bufuralol
Le polymorphisme génétique de l'oxydation des médicaments: son importance dans l'emploi des médicaments antihypertenseurs.